Dr. Mukund G. Shah, MD

Dr. Shah practices at Antelope Valley Cancer Center in Palmdale, California.

Dr. Shah's NPI, 1801977632, was assigned on October 18, 2006. Dr. Shah holds California license A31073.

Dr. Shah's primary practice is Antelope Valley Cancer Center, at 607 W S Ave, Palmdale, CA 93551 in Los Angeles County. The practice phone is (661) 948-5928.

Dr. Shah's primary practice is Antelope Valley Cancer Center in Palmdale, California. Dr. Shah is also affiliated with Ridgecrest Regional Hospital. The medical group on file is Antelope Valley Cancer Center. Dmand AI also links Dr. Shah to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shah is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Shah's licenses on file in 3 states: California, Georgia and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Shah treats.

CMS data shows 7,105 Medicare services from Dr. Shah across 20 procedure codes in 2024, for 280 Medicare patients. Medicare paid $286,930 for them. Every service was in an office.

CMS counts 280 Medicare patients who saw Dr. Shah in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 57, with 66% women.

In 2024, Dr. Shah wrote 98 Medicare Part D claims for 40 patients. 59% of them were for generic drugs. CMS names the drug for 38 of them, across 2 drugs with 11 or more claims each, at $290,330 in total drug cost. In 2023, CMS named 336 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shah for performance year 2024, reported individually. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Shah to 1 clinical trial. Conditions studied include Adenocarcinoma Of Esophagus and Stomach Neoplasms.

CMS Open Payments shows 295 general payments to Dr. Shah from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Genentech, Inc. paid the most, $1,309.

Dmand AI lists 1 award for Dr. Shah, most recently CMS Stage 1 2012 in 2011.

Dr. Shah is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.